One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Key Takeaways An experimental drug can delay disability progression in advanced multiple sclerosis patientsTolebrutinib ...

The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step ...

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

WEDNESDAY, April 9, 2025 (HealthDay News) -- An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The AI models occasionally altered decisions based on patients’ personal characteristics, affecting priority for care and ...